How does bosutinib treat ALS?

Bosutinib (Bosutinib) is a tyrosine kinase inhibitor mainly used to treat chronic myeloid leukemia (CML). Currently, there is insufficient evidence that bosutinib is effective in treating Amyotrophic Lateral Sclerosis. ALS is a degenerative disease of the nervous system, also known as amyotrophic lateral sclerosis. There is currently no specific drug that can cure or prevent its progression. The treatment of ALS requires comprehensive treatment under the guidance of a doctor, including drug treatment, rehabilitation training, psychological support, etc. But research in recent years has shown that it may also have a certain therapeutic effect on ALS. Patients should be treated with bosutinib under the guidance of a doctor.